MX350541B - Materiales y metodos para mejorar la funcion gastrointestinal. - Google Patents
Materiales y metodos para mejorar la funcion gastrointestinal.Info
- Publication number
- MX350541B MX350541B MX2015017157A MX2015017157A MX350541B MX 350541 B MX350541 B MX 350541B MX 2015017157 A MX2015017157 A MX 2015017157A MX 2015017157 A MX2015017157 A MX 2015017157A MX 350541 B MX350541 B MX 350541B
- Authority
- MX
- Mexico
- Prior art keywords
- materials
- methods
- gastrointestinal function
- improve gastrointestinal
- improve
- Prior art date
Links
- 230000007661 gastrointestinal function Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/788—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38631710P | 2010-09-24 | 2010-09-24 | |
| US201161431629P | 2011-01-11 | 2011-01-11 | |
| PCT/US2011/053265 WO2012040707A2 (en) | 2010-09-24 | 2011-09-26 | Materials and methods for improving gastrointestinal function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX350541B true MX350541B (es) | 2017-09-08 |
Family
ID=45871248
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013003282A MX2013003282A (es) | 2010-09-24 | 2011-09-26 | Materiales y metodos para mejorar la funcion gastrointestinal. |
| MX2015017157A MX350541B (es) | 2010-09-24 | 2011-09-26 | Materiales y metodos para mejorar la funcion gastrointestinal. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013003282A MX2013003282A (es) | 2010-09-24 | 2011-09-26 | Materiales y metodos para mejorar la funcion gastrointestinal. |
Country Status (17)
| Country | Link |
|---|---|
| US (7) | US8993522B2 (enExample) |
| EP (5) | EP3494969B1 (enExample) |
| JP (3) | JP6000253B2 (enExample) |
| KR (4) | KR101758424B1 (enExample) |
| CN (2) | CN103153298B (enExample) |
| AP (1) | AP2013006826A0 (enExample) |
| AU (2) | AU2011305124B2 (enExample) |
| BR (1) | BR112013006044B1 (enExample) |
| CA (1) | CA2809489C (enExample) |
| EA (1) | EA030970B8 (enExample) |
| ES (2) | ES2639888T3 (enExample) |
| IL (1) | IL277166B (enExample) |
| MX (2) | MX2013003282A (enExample) |
| NZ (1) | NZ607189A (enExample) |
| PH (1) | PH12013500441A1 (enExample) |
| SG (1) | SG188293A1 (enExample) |
| WO (1) | WO2012040707A2 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013003282A (es) * | 2010-09-24 | 2013-05-09 | Univ Florida | Materiales y metodos para mejorar la funcion gastrointestinal. |
| KR102584819B1 (ko) * | 2011-01-19 | 2023-10-05 | 프랙틸 헬쓰, 인코포레이티드 | 조직의 치료를 위한 장치 및 방법 |
| MX368543B (es) * | 2012-02-08 | 2019-10-07 | Univ Florida | Composiciones para tratar diarrea inducida por rotavirus. |
| CN110522744B (zh) | 2013-03-11 | 2023-04-07 | 佛罗里达大学研究基金会有限公司 | 用于改善肺功能和用于预防和/或治疗辐射诱发的肺并发症的材料和方法 |
| US10258810B2 (en) | 2013-09-27 | 2019-04-16 | Mevion Medical Systems, Inc. | Particle beam scanning |
| US9962560B2 (en) | 2013-12-20 | 2018-05-08 | Mevion Medical Systems, Inc. | Collimator and energy degrader |
| US10675487B2 (en) | 2013-12-20 | 2020-06-09 | Mevion Medical Systems, Inc. | Energy degrader enabling high-speed energy switching |
| US9661736B2 (en) | 2014-02-20 | 2017-05-23 | Mevion Medical Systems, Inc. | Scanning system for a particle therapy system |
| US20170326088A1 (en) | 2014-11-24 | 2017-11-16 | Entrinsic Health Solutions, Llc | Amino acid compositions for the treatment of symptoms of disease |
| WO2016127070A1 (en) * | 2015-02-05 | 2016-08-11 | University Of Flordia Research Foundation, Inc. | Use of nhe3 as biomarker for radiation biodosimetry |
| US20160339086A1 (en) * | 2015-05-19 | 2016-11-24 | Suzy Cohen | Compositions and methods for treating thyroid disease |
| US10786689B2 (en) | 2015-11-10 | 2020-09-29 | Mevion Medical Systems, Inc. | Adaptive aperture |
| CN105685973B (zh) * | 2016-02-04 | 2018-08-24 | 中山大学附属第六医院 | 一种肠内营养剂 |
| US10702590B2 (en) | 2016-04-12 | 2020-07-07 | Script Essentials, Llc | Compositions and methods for treating thyroid disease |
| CN109803723B (zh) | 2016-07-08 | 2021-05-14 | 迈胜医疗设备有限公司 | 一种粒子疗法系统 |
| EP3494968A4 (en) * | 2016-08-05 | 2020-04-15 | The University Of Tokyo | COMPOSITION FOR USE IN TREATING T-CELL LEUKEMIA / LYMPHOMA IN ADULTS AND METHOD FOR THE PRODUCTION THEREOF |
| EP3522882A4 (en) * | 2016-10-04 | 2020-06-24 | The University of Florida Research Foundation Incorporated | AMINO ACID COMPOSITIONS AND USES THEREOF |
| US11103730B2 (en) | 2017-02-23 | 2021-08-31 | Mevion Medical Systems, Inc. | Automated treatment in particle therapy |
| US10653892B2 (en) | 2017-06-30 | 2020-05-19 | Mevion Medical Systems, Inc. | Configurable collimator controlled using linear motors |
| US12109191B2 (en) | 2017-10-02 | 2024-10-08 | Amilyfe, Llc | Materials and methods for inhibiting tumor growth |
| WO2019070753A1 (en) * | 2017-10-02 | 2019-04-11 | University Of Florida Research Foundation, Incorporated | AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA |
| WO2019195594A1 (en) * | 2018-04-04 | 2019-10-10 | University Of Florida Research Foundation, Incorporated | Compositions for treating skin |
| CN109601761A (zh) * | 2018-11-01 | 2019-04-12 | 山东大学 | 一种大菱鲆肠炎病的营养性修复剂 |
| WO2020185543A1 (en) | 2019-03-08 | 2020-09-17 | Mevion Medical Systems, Inc. | Collimator and energy degrader for a particle therapy system |
| US20200352968A1 (en) * | 2019-04-26 | 2020-11-12 | Increvet, Inc. | Methods for reducing the weight loss or increasing the weight of a feline in need thereof |
| RU2699222C1 (ru) * | 2019-04-29 | 2019-09-04 | Алексей Владимирович Воронов | Солевой электролитный раствор для проведения энтеральных инфузий |
| JP7293406B2 (ja) * | 2019-06-14 | 2023-06-19 | シージェイ チェルジェダン コーポレイション | コリネバクテリウム属菌株およびその培養物を含む胃腸疾患予防、治療または改善用組成物 |
| EP4058044A4 (en) * | 2019-11-11 | 2023-05-17 | Ohio State Innovation Foundation | TREATMENT OF INFLAMMATORY BOWEL DISEASE AND RADIATION INDUCED BOWEL DAMAGE |
| IT202000000442A1 (it) | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia |
| AU2021284284A1 (en) * | 2020-06-02 | 2022-11-17 | Amilyfe, Llc | Formulations and methods for treating diarrhea |
| AU2021300188A1 (en) * | 2020-07-02 | 2023-02-02 | Amilyfe, Llc | Formulations for promoting hydration and methods of use thereof |
| IT202200013354A1 (it) * | 2022-06-23 | 2023-12-23 | Professional Dietetics Spa | Composizioni comprendenti amminoacidi per l'uso nella prevenzione e/o nel trattamento di malattie intestinali |
| US11878073B1 (en) | 2022-09-20 | 2024-01-23 | Entrinsic, LLC | Generation of hydration-targeted formulations and methods of use therein |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1285491C (en) * | 1985-09-12 | 1991-07-02 | Robert J. Smith | Method of treating catabolic dysfunction |
| SE8601828D0 (sv) | 1986-04-21 | 1986-04-21 | Novo Industri As | Enteral diet product and agent for production thereof |
| US5254572A (en) * | 1987-11-27 | 1993-10-19 | Vesta Medicines (Pty) Ltd. | Method and composition for supplementing vitamin B6 where the PN-PLP pathway is disturbed |
| US5290538A (en) | 1988-12-22 | 1994-03-01 | Skrezek Christian | Nephro protective infusion solutions |
| ES2179068T3 (es) | 1991-03-05 | 2003-01-16 | Aradigm Corp | Metodo y dispositivo para corregir el desplazamiento de deriva de un detector de presion de flujo. |
| ES2141108T3 (es) | 1991-07-02 | 2000-03-16 | Inhale Inc | Metodo y dispositivo para proporcionar medicamentos en aerosol. |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US5514656A (en) | 1993-05-28 | 1996-05-07 | Abbott Laboratories | Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy |
| NZ248605A (en) | 1993-05-28 | 1994-12-22 | Abbott Lab | Enteral nutritional product comprising protein and fat |
| JP3177918B2 (ja) * | 1993-06-24 | 2001-06-18 | 日本電信電話株式会社 | パケット交換機のルーチング装置 |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| US5780451A (en) * | 1994-04-01 | 1998-07-14 | Abbott Laboratories | Nutritional product for a person having ulcerative colitis |
| JPH07330583A (ja) * | 1994-06-03 | 1995-12-19 | Terumo Corp | 遊離型グルタミン酸を含有する液状製剤 |
| JPH0873351A (ja) * | 1994-06-30 | 1996-03-19 | Ajinomoto Co Inc | 炎症性腸疾患用栄養組成物 |
| EP0689835A3 (en) | 1994-06-30 | 1996-04-17 | Ajinomoto Kk | Composition containing an amino acid mixture and at least one N-3 fatty acid |
| JP4011638B2 (ja) * | 1994-12-27 | 2007-11-21 | イーエヌ大塚製薬株式会社 | 経口経腸栄養組成物 |
| FI972744A7 (fi) | 1995-02-23 | 1997-08-22 | Novartis Nutrition Ag | Aminohappokokoonpanoja ja niiden käyttö kliinisessä ravinnossa |
| EP0820277B1 (en) | 1995-04-14 | 2005-01-26 | Nektar Therapeutics | Powdered pharmaceutical formulations having improved dispersibility |
| JPH11507831A (ja) | 1995-06-14 | 1999-07-13 | ベイラー・カレッジ・オブ・メディスン | ロタウイルスエンテロトキシンｎｓｐ４およびそれを用いる方法 |
| US6673355B1 (en) | 1995-06-14 | 2004-01-06 | Baylor College Of Medicine | Rotavirus enterotoxin NSP4 and methods of using same |
| US5821217A (en) | 1995-10-27 | 1998-10-13 | Beth Israel Deaconess Medical Center, Inc. | Enteral formulation: low in fat and containing protein hydrolysates |
| US6001336A (en) | 1996-12-31 | 1999-12-14 | Inhale Therapeutic Systems | Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof |
| JP2002542145A (ja) | 1998-11-13 | 2002-12-10 | チルドレンズ・ホスピタル・オヴ・ロス・アンジェルス | 血管成長を促進する方法 |
| HK1042825A1 (zh) | 1998-12-22 | 2002-08-30 | The University Of North Carolina At Chapel Hill | 治疗气道疾病的化合物和方法以及气道药物的给药方法 |
| GB0009056D0 (en) * | 2000-04-12 | 2000-05-31 | Nestle Sa | Composition comprising free amino acids |
| US6956023B1 (en) * | 2001-04-19 | 2005-10-18 | University Of Florida | Materials and methods for providing nutrition to neonates |
| JP4255656B2 (ja) | 2001-09-17 | 2009-04-15 | 株式会社メニコン | 眼科用液剤及びコンタクトレンズ用液剤 |
| US20030105104A1 (en) | 2001-11-27 | 2003-06-05 | Burzynski Stanislaw R. | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| US20030143293A1 (en) | 2002-01-31 | 2003-07-31 | Sergei Shushunov | Compositions and methods for treating diarrhea |
| JP2004123642A (ja) | 2002-10-04 | 2004-04-22 | Shimizu Pharmaceutical Co Ltd | 電解質組成物 |
| DK175877B1 (da) | 2002-11-11 | 2005-05-09 | Pharmalett As | Præparater til anvendelse som terapeutisk middel |
| US20040213838A1 (en) | 2003-04-24 | 2004-10-28 | Mazer Terrence B. | Medical food tablets containing free amino acids |
| US20050100637A1 (en) | 2003-11-12 | 2005-05-12 | Robert Murray | Carbohydrate and electrolyte replacement composition |
| JPWO2006049286A1 (ja) | 2004-11-02 | 2008-05-29 | 味の素株式会社 | アレルギー性疾患予防・治療剤 |
| US20070010459A1 (en) | 2005-01-14 | 2007-01-11 | Ying Liu | Application of asiatic acid and its derivatives to treat pulmonary fibrosis |
| GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
| JP4811576B2 (ja) | 2005-03-31 | 2011-11-09 | 味の素株式会社 | 水分電解質補給飲料 |
| JPWO2007004613A1 (ja) | 2005-07-01 | 2009-01-29 | 味の素株式会社 | 炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤 |
| US7595079B2 (en) | 2005-07-08 | 2009-09-29 | Bomac Vets Plus, Inc. | Nutritional conjunctive support therapy for recovery in animals following stress or illness |
| JP4512013B2 (ja) | 2005-09-07 | 2010-07-28 | 和光堂株式会社 | 液体飲料組成物及びその製造方法 |
| US20070202058A1 (en) | 2006-02-27 | 2007-08-30 | Calwood Nutritionals, Inc. | Compositions for treating gastric reflux |
| CN100522183C (zh) | 2006-03-02 | 2009-08-05 | 上海交通大学 | 治疗咳喘病的地龙酸性部位药及其制备方法 |
| EP1864692A1 (en) | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
| DE102006018293A1 (de) | 2006-04-20 | 2007-10-25 | Fresenius Kabi Deutschland Gmbh | Pädiatrische Aminosäurelösung zur parenteralen Ernäherung |
| WO2007133642A1 (en) * | 2006-05-11 | 2007-11-22 | Garcia Ramon D | Sport drink containing amino acids and carbohydrates |
| CN101437413A (zh) | 2006-05-12 | 2009-05-20 | 可口可乐公司 | 饮料防腐剂 |
| JP5100033B2 (ja) | 2006-05-16 | 2012-12-19 | 大塚製薬株式会社 | 消化管及び腎臓の萎縮抑制剤 |
| GB0612671D0 (en) * | 2006-06-27 | 2006-08-09 | Shs Int Ltd | Nutritional formulation |
| CN101795579A (zh) | 2006-08-04 | 2010-08-04 | Shs国际有限公司 | 无蛋白配方 |
| BRPI0814745A2 (pt) | 2007-08-03 | 2014-10-07 | Aminotech As | Composição de produto. |
| CN101951930A (zh) | 2008-02-19 | 2011-01-19 | 阿奈斯特药品株式会社 | 对身体功能的恢复有用的口服或经肠组合物 |
| US20090318556A1 (en) | 2008-05-15 | 2009-12-24 | Idle Jeffrey R | Biomarkers for detecting radiation exposure: methods and uses thereof |
| JP5576097B2 (ja) | 2009-11-17 | 2014-08-20 | 大塚製薬株式会社 | 気道抵抗改善剤 |
| IT1396935B1 (it) | 2009-11-26 | 2012-12-20 | Solartium Entpr Ltd | Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici |
| CN101779750A (zh) * | 2010-03-24 | 2010-07-21 | 舒世洪 | 一种乳猪教槽料及制备方法 |
| WO2011127056A2 (en) | 2010-04-05 | 2011-10-13 | The Uab Research Foundation | Biomarkers for assessing exposure to ionizing radiation and absorbed dose |
| WO2012020357A1 (en) | 2010-08-09 | 2012-02-16 | Advinus Therapeutics Ltd. | Acetamide compounds, their process and pharmaceutical application |
| MX2013003282A (es) | 2010-09-24 | 2013-05-09 | Univ Florida | Materiales y metodos para mejorar la funcion gastrointestinal. |
| US20120321729A1 (en) | 2011-06-15 | 2012-12-20 | Ven Subbiah | Nutritional formula for managing chronic obstructive pulmonary disease (copd) and lung health |
| US8557301B2 (en) | 2011-07-01 | 2013-10-15 | Drip Drop, Inc. | Oral rehydration composition |
| MX368543B (es) | 2012-02-08 | 2019-10-07 | Univ Florida | Composiciones para tratar diarrea inducida por rotavirus. |
| WO2013151744A1 (en) | 2012-04-05 | 2013-10-10 | University Of Florida Research Foundation, Inc. | Materials and methods for treatment of cystic fibrosis and for induction of ion secretion |
| CN110522744B (zh) | 2013-03-11 | 2023-04-07 | 佛罗里达大学研究基金会有限公司 | 用于改善肺功能和用于预防和/或治疗辐射诱发的肺并发症的材料和方法 |
| AU2017204949B2 (en) | 2016-01-06 | 2020-01-16 | Parasonic Ltd. | Device and method for damaging parasites using ultrasonic reflection |
| EP3522882A4 (en) | 2016-10-04 | 2020-06-24 | The University of Florida Research Foundation Incorporated | AMINO ACID COMPOSITIONS AND USES THEREOF |
-
2011
- 2011-09-26 MX MX2013003282A patent/MX2013003282A/es unknown
- 2011-09-26 EP EP18213818.0A patent/EP3494969B1/en active Active
- 2011-09-26 CA CA2809489A patent/CA2809489C/en active Active
- 2011-09-26 EP EP24162436.0A patent/EP4406557A3/en active Pending
- 2011-09-26 BR BR112013006044-1A patent/BR112013006044B1/pt active IP Right Grant
- 2011-09-26 EP EP11827720.1A patent/EP2624825B1/en active Active
- 2011-09-26 WO PCT/US2011/053265 patent/WO2012040707A2/en not_active Ceased
- 2011-09-26 KR KR1020137007214A patent/KR101758424B1/ko active Active
- 2011-09-26 KR KR1020187035048A patent/KR102069790B1/ko active Active
- 2011-09-26 KR KR1020177019051A patent/KR20170084354A/ko not_active Ceased
- 2011-09-26 CN CN201180045566.0A patent/CN103153298B/zh active Active
- 2011-09-26 EA EA201300323A patent/EA030970B8/ru not_active IP Right Cessation
- 2011-09-26 SG SG2013013883A patent/SG188293A1/en unknown
- 2011-09-26 CN CN201510691368.1A patent/CN105663106A/zh active Pending
- 2011-09-26 EP EP21159441.1A patent/EP3970715A1/en active Pending
- 2011-09-26 US US13/245,430 patent/US8993522B2/en active Active
- 2011-09-26 MX MX2015017157A patent/MX350541B/es unknown
- 2011-09-26 AU AU2011305124A patent/AU2011305124B2/en active Active
- 2011-09-26 EP EP16201706.5A patent/EP3173079B1/en active Active
- 2011-09-26 JP JP2013530396A patent/JP6000253B2/ja active Active
- 2011-09-26 ES ES11827720.1T patent/ES2639888T3/es active Active
- 2011-09-26 AP AP2013006826A patent/AP2013006826A0/xx unknown
- 2011-09-26 KR KR1020207001701A patent/KR102205124B1/ko active Active
- 2011-09-26 NZ NZ60718911A patent/NZ607189A/en not_active IP Right Cessation
- 2011-09-26 ES ES16201706T patent/ES2805535T3/es active Active
- 2011-09-26 PH PH1/2013/500441A patent/PH12013500441A1/en unknown
-
2015
- 2015-03-12 US US14/656,255 patent/US10322109B2/en active Active
- 2015-07-30 AU AU2015207919A patent/AU2015207919B2/en active Active
-
2016
- 2016-08-30 JP JP2016167829A patent/JP6425356B2/ja active Active
-
2018
- 2018-10-02 JP JP2018187236A patent/JP6698777B2/ja active Active
- 2018-10-18 US US16/164,399 patent/US20190046504A1/en not_active Abandoned
-
2019
- 2019-06-14 US US16/441,062 patent/US10940137B2/en active Active
-
2020
- 2020-09-06 IL IL277166A patent/IL277166B/en active IP Right Grant
-
2021
- 2021-01-29 US US17/161,811 patent/US11752132B2/en active Active
-
2023
- 2023-08-01 US US18/363,448 patent/US12239633B2/en active Active
-
2025
- 2025-01-16 US US19/023,953 patent/US20250248972A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX350541B (es) | Materiales y metodos para mejorar la funcion gastrointestinal. | |
| CL2013000018A1 (es) | Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros. | |
| UY33029A (es) | Antagonistas de espiro-oxindol de mdm2 | |
| CL2011003350A1 (es) | Compuestos derivados de heterociclo nitrogenados, moduladores pkm2; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer. | |
| CO6721010A2 (es) | Antagonistas de mdm2 de espiro-oxindol | |
| CL2013000016A1 (es) | Compuestos derivados de imidazopiridina; procedimiento de preparacion; composicion farmaceutica y su uso en el tratamiento del cancer. | |
| AR075442A1 (es) | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia | |
| EP2441453A4 (en) | PHARMACEUTICAL COMPOSITION FOR HUMAN AND ANIMAL MEDICINE OPHTHALMOLOGY | |
| MX362103B (es) | Composiciones para el cuidado oral para su uso con un dispositivo oral con luz. | |
| ECSP11011459A (es) | Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas | |
| CL2014002557A1 (es) | Compuestos bicíclicos de pirazinona; procedimiento de preparacion; composicion farmaceutica; kit; y uso en el tratamiento y/o prevencion de enfermedades cardiovasculares, cancer, entre otras. | |
| CL2008001123A1 (es) | Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
| BRPI1006040A2 (pt) | uso de composições farmacêuticas, tipo de curativo médico, e, tipo de caixa de medicamento | |
| AR084652A1 (es) | Glicoles como agentes inactivadores de patogenos | |
| PE20142457A1 (es) | Compuestos heterociclicos y sus usos | |
| CL2017000884A1 (es) | Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica | |
| ECSP13012988A (es) | Derivados de tienopirimidina (2,3-d) y su uso para tratar arritmia | |
| CO6602160A2 (es) | Terapia de b12 oral | |
| CO6480929A2 (es) | Procedimiento de uso del factor liberador de corticotropina para el tratamiento del cancer | |
| CR20120617A (es) | Combinación de inhibidores de xantna oxidasa y antagonistas del receptor de angiotensina ii y su uso | |
| ECSP15005163A (es) | Composiciones líquidas orales pediátricas que contienen nepadutant | |
| CO6640306A2 (es) | Combinación de inhibidores de xantina oxidasa y antagonistas del receptor de angiotensina ii y su uso | |
| PE20140697A1 (es) | Combinacion y composicion para el tratamiento de obsidad | |
| CL2012000355A1 (es) | Compuestos derivados de 4-amino-butenamida; composicion farmaceutica; y uso en el tratamiento de la epoc. | |
| CL2009001327A1 (es) | Compuestos heterociclo derivados de 3-oxoisoindolin-1-carboxamida; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento del dolor. |